EBSWORTH DAVID R

CIK 00012071072 companiesLONDON, X0

SEC Profile

Transactions

Companies

Filings

CIK

0001207107

Recent Transactions

35 trades

Disposition to Issuer
Verona Pharma plc$VRNA
Ordinary Shares
2025-10-07−880,499→ 0 total
Exercise/Conversion
Verona Pharma plc$VRNA
Restricted Share Unit
2025-10-07−72,000→ 0 total
Disposition to Issuer
Verona Pharma plc$VRNA
Ordinary Shares
2025-10-07−617,600→ 0 total
Exercise/Conversion
Verona Pharma plc$VRNA
Ordinary Shares
2025-10-07+72,000→ 72,000 total
Disposition to Issuer
Verona Pharma plc$VRNA
Ordinary Shares
2025-10-07−72,000→ 0 total
Sale
Verona Pharma plc$VRNA
Ordinary Shares
2025-08-01$13.14/sh−1,904→ 880,499 total
Exercise/Conversion
Verona Pharma plc$VRNA
Restricted Stock Units
2025-08-01−24,000→ 72,000 total
Exercise/Conversion
Verona Pharma plc$VRNA
Ordinary Shares
2025-08-01+24,000→ 882,403 total
Exercise/Conversion
Verona Pharma plc$VRNA
Stock Option (Right to Exercise)
2025-05-01+140,000→ 0 total
Exercise/Conversion
Verona Pharma plc$VRNA
Ordinary Shares
2025-05-01$1.93/sh+140,000→ 1,476,003 total
Award
Verona Pharma plc$VRNA
Restricted Share Units
2025-04-25+96,000→ 96,000 total
Gift
Verona Pharma plc$VRNA
Ordinary Shares
2025-02-26−64,000→ 1,336,003 total
Exercise/Conversion
Verona Pharma plc$VRNA
Ordinary Shares
2025-02-26$0.78/sh+64,000→ 1,004,003 total
Exercise/Conversion
Verona Pharma plc$VRNA
Ordinary Shares
2025-02-26$0.50/sh+200,000→ 1,204,003 total
Exercise/Conversion
Verona Pharma plc$VRNA
Ordinary Shares
2025-02-26$1.93/sh+100,000→ 1,400,003 total
Exercise/Conversion
Verona Pharma plc$VRNA
Share Option (Right to Exercise)
2025-02-26−200,000→ 0 total
Exercise/Conversion
Verona Pharma plc$VRNA
Share Option (Right to Exercise)
2025-02-26−96,000→ 0 total
Exercise/Conversion
Verona Pharma plc$VRNA
Ordinary Shares
2025-02-26$2.67/sh+96,000→ 1,300,003 total
Exercise/Conversion
Verona Pharma plc$VRNA
Share Option (Right to Exercise)
2025-02-26−64,000→ 0 total
Exercise/Conversion
Verona Pharma plc$VRNA
Share Option (Right to Exercise)
2025-02-26−100,000→ 140,000 total
Purchase
Verona Pharma plc$VRNA
Ordinary Shares
2024-11-18$4.44/sh+20,000→ 940,003 total
Purchase
Verona Pharma plc$VRNA
Ordinary Shares
2024-11-06$4.80/sh+39,360→ 920,003 total
Purchase
Verona Pharma plc$VRNA
Ordinary Shares
2024-08-12$2.87/sh+36,000→ 880,643 total
Award
Verona Pharma plc$VRNA
Share Options (Right to Buy)
2024-04-29+240,000→ 240,000 total
Purchase
Verona Pharma plc$VRNA
Ordinary Shares
2023-11-06$1.98/sh+160,000→ 844,643 total
Award
Verona Pharma plc$VRNA
Share Options (Right to Buy)
2023-04-28+96,000→ 96,000 total
Award
Verona Pharma plc$VRNA
Share Options (Right to Buy)
2022-04-28+200,000→ 200,000 total
Award
Verona Pharma plc$VRNA
Share Options (Right to Buy)
2021-08-09+64,000→ 64,000 total
Sale
Verona Pharma plc$VRNA
Ordinary Shares
2021-05-04$0.84/sh−11,184→ 684,643 total
Sale
Verona Pharma plc$VRNA
Ordinary Shares
2021-02-01$0.99/sh−11,912→ 695,827 total
Award
CURAGEN CORP
Common Stock (Right to Buy)
2006-05-03$3.85/sh+2,500→ 2,500 total
Award
CURAGEN CORP
Common Stock (Right to Buy)
2006-05-03$3.85/sh+15,000→ 15,000 total
Purchase
CURAGEN CORP
Common Stock
2004-05-27$5.27/sh+9,500→ 10,000 total
Award
CURAGEN CORP
Stock Option (Right to Buy)
2004-05-26$5.34/sh+2,500→ 2,500 total
Award
CURAGEN CORP
Stock Option (Right to Buy)
2004-05-26$5.34/sh+12,500→ 12,500 total

Companies

Recent Filings

Address

3 MORE LONDON RIVERSIDE

LONDON, X0, SE1 2RE

View on SEC.gov